US Stock MarketDetailed Quotes

Niagen Bioscience (NAGE)

Watchlist
  • 3.500
  • +0.060+1.74%
Close Jun 4 15:59 ET
278.76MMarket Cap16.67P/E (TTM)

Niagen Bioscience (NAGE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-115.15%-1.19M
11.52%13.5M
-92.09%679K
5.64%3.69M
573.48%1.25M
2,572.20%7.88M
70.14%12.11M
1,222.50%8.58M
782.58%3.5M
-108.05%-264K
Net income from continuing operations
24.79%6.32M
103.30%17.38M
-42.44%4.13M
143.77%4.58M
24,160.00%3.61M
1,129.07%5.06M
273.15%8.55M
6,197.37%7.18M
295.83%1.88M
99.32%-15K
Operating gains losses
-119,700.00%-4.78M
121.05%4K
--0
--0
--0
--4K
-280.00%-19K
--0
---20K
----
Depreciation and amortization
26.09%464K
-2.29%1.45M
2.79%368K
-1.91%359K
-4.05%355K
-5.64%368K
-12.96%1.48M
-4.02%358K
-18.30%366K
-16.67%370K
Other non cash items
281.13%96K
44.61%-1.95M
46.26%-1.93M
-28.57%15K
-35.00%13K
-352.38%-53K
-23,593.33%-3.52M
---3.59M
--21K
266.67%20K
Change In working capital
-285.26%-5.09M
-355.83%-8.23M
-170.64%-3.67M
-697.22%-3M
-134.30%-4.3M
527.22%2.75M
-30.40%3.22M
669.52%5.19M
219.19%503K
-155.92%-1.84M
-Change in receivables
-267.50%-3.41M
40.89%-756K
-296.57%-1.26M
63.66%1.16M
-119.66%-2.69M
244.98%2.04M
-156.72%-1.28M
84.48%642K
119.81%710K
-145.95%-1.23M
-Change in inventory
-79.28%-3.57M
-318.17%-11.64M
-250.59%-2.04M
-553.46%-4.39M
-427.34%-3.22M
-198.18%-1.99M
3,408.55%5.33M
171.12%1.35M
248.54%967K
1,613.85%984K
-Change in prepaid assets
-945.00%-169K
2,591.11%1.12M
308.96%746K
1,066.67%87K
24.65%268K
-81.13%20K
-107.13%-45K
-162.50%-357K
96.43%-9K
-46.65%215K
-Change in payables and accrued expense
-28.72%2.38M
2,857.55%4.11M
-129.33%-988K
264.94%381K
184.19%1.38M
345.33%3.34M
-94.87%139K
152.55%3.37M
-182.21%-231K
-398.36%-1.64M
-Change in other current liabilities
3.98%-241K
-54.31%-949K
2.48%-236K
-3.56%-233K
-129.00%-229K
-422.92%-251K
-18.50%-615K
-272.31%-242K
-53.06%-225K
27.54%-100K
-Change in other working capital
81.73%-74K
61.39%-122K
-75.12%107K
97.74%-16K
366.67%192K
-1,257.14%-405K
47.85%-316K
187.40%430K
-3,054.17%-709K
45.45%-72K
Cash from discontinued investing activities
Operating cash flow
-115.15%-1.19M
11.52%13.5M
-92.09%679K
5.64%3.69M
573.48%1.25M
2,572.20%7.88M
70.14%12.11M
1,222.50%8.58M
782.58%3.5M
-108.05%-264K
Investing cash flow
Cash flow from continuing investing activities
16,490.63%5.25M
-104.20%-292K
-46.38%-101K
-14.29%-24K
-1,025.00%-135K
21.95%-32K
0.00%-143K
-228.57%-69K
19.23%-21K
-140.00%-12K
Net PPE purchase and sale
-90.63%-61K
-104.20%-292K
-46.38%-101K
-14.29%-24K
-1,025.00%-135K
21.95%-32K
0.00%-143K
-228.57%-69K
19.23%-21K
-140.00%-12K
Net business purchase and sale
--5.8M
----
----
----
----
----
----
----
----
----
Net other investing changes
---494K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
16,490.63%5.25M
-104.20%-292K
-46.38%-101K
-14.29%-24K
-1,025.00%-135K
21.95%-32K
0.00%-143K
-228.57%-69K
19.23%-21K
-140.00%-12K
Financing cash flow
Cash flow from continuing financing activities
-173.75%-2.29M
28.81%6.92M
-102.13%-80K
-85.76%148K
528.02%3.74M
22,278.57%3.11M
6,065.56%5.37M
5,031.58%3.75M
34,733.33%1.04M
6,060.00%596K
Net issuance payments of debt
--0
-9.09%-12K
0.00%-2K
0.00%-4K
-50.00%-3K
0.00%-3K
26.67%-11K
-100.00%-2K
-33.33%-4K
80.00%-2K
Net common stock issuance
---2.35M
---251K
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
-96.44%111K
33.39%7.25M
-93.99%228K
-85.43%152K
527.42%3.75M
--3.11M
--5.43M
--3.79M
--1.04M
--598K
Net other financing activities
-683.33%-47K
-28.85%-67K
-34.15%-55K
--0
---6K
45.45%-6K
30.67%-52K
---41K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-173.75%-2.29M
28.81%6.92M
-102.13%-80K
-85.76%148K
528.02%3.74M
22,278.57%3.11M
6,065.56%5.37M
5,031.58%3.75M
34,733.33%1.04M
6,060.00%596K
Net cash flow
Beginning cash position
45.07%64.79M
63.44%44.66M
98.44%64.29M
116.87%60.47M
101.76%55.62M
63.44%44.66M
33.68%27.33M
21.01%32.4M
5.60%27.89M
19.12%27.57M
Current changes in cash
-83.93%1.76M
16.11%20.13M
-95.94%498K
-15.44%3.82M
1,418.13%4.86M
4,465.00%10.96M
151.82%17.34M
2,121.38%12.26M
1,129.70%4.51M
-90.20%320K
End cash Position
19.66%66.55M
45.07%64.79M
45.07%64.79M
98.44%64.29M
116.87%60.47M
101.76%55.62M
63.44%44.66M
63.44%44.66M
21.01%32.4M
5.60%27.89M
Free cash flow
-115.99%-1.26M
10.60%13.21M
-93.21%578K
6.20%3.67M
503.99%1.12M
2,990.94%7.85M
71.42%11.95M
1,255.73%8.51M
833.51%3.45M
-108.44%-276K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -115.15%-1.19M11.52%13.5M-92.09%679K5.64%3.69M573.48%1.25M2,572.20%7.88M70.14%12.11M1,222.50%8.58M782.58%3.5M-108.05%-264K
Net income from continuing operations 24.79%6.32M103.30%17.38M-42.44%4.13M143.77%4.58M24,160.00%3.61M1,129.07%5.06M273.15%8.55M6,197.37%7.18M295.83%1.88M99.32%-15K
Operating gains losses -119,700.00%-4.78M121.05%4K--0--0--0--4K-280.00%-19K--0---20K----
Depreciation and amortization 26.09%464K-2.29%1.45M2.79%368K-1.91%359K-4.05%355K-5.64%368K-12.96%1.48M-4.02%358K-18.30%366K-16.67%370K
Other non cash items 281.13%96K44.61%-1.95M46.26%-1.93M-28.57%15K-35.00%13K-352.38%-53K-23,593.33%-3.52M---3.59M--21K266.67%20K
Change In working capital -285.26%-5.09M-355.83%-8.23M-170.64%-3.67M-697.22%-3M-134.30%-4.3M527.22%2.75M-30.40%3.22M669.52%5.19M219.19%503K-155.92%-1.84M
-Change in receivables -267.50%-3.41M40.89%-756K-296.57%-1.26M63.66%1.16M-119.66%-2.69M244.98%2.04M-156.72%-1.28M84.48%642K119.81%710K-145.95%-1.23M
-Change in inventory -79.28%-3.57M-318.17%-11.64M-250.59%-2.04M-553.46%-4.39M-427.34%-3.22M-198.18%-1.99M3,408.55%5.33M171.12%1.35M248.54%967K1,613.85%984K
-Change in prepaid assets -945.00%-169K2,591.11%1.12M308.96%746K1,066.67%87K24.65%268K-81.13%20K-107.13%-45K-162.50%-357K96.43%-9K-46.65%215K
-Change in payables and accrued expense -28.72%2.38M2,857.55%4.11M-129.33%-988K264.94%381K184.19%1.38M345.33%3.34M-94.87%139K152.55%3.37M-182.21%-231K-398.36%-1.64M
-Change in other current liabilities 3.98%-241K-54.31%-949K2.48%-236K-3.56%-233K-129.00%-229K-422.92%-251K-18.50%-615K-272.31%-242K-53.06%-225K27.54%-100K
-Change in other working capital 81.73%-74K61.39%-122K-75.12%107K97.74%-16K366.67%192K-1,257.14%-405K47.85%-316K187.40%430K-3,054.17%-709K45.45%-72K
Cash from discontinued investing activities
Operating cash flow -115.15%-1.19M11.52%13.5M-92.09%679K5.64%3.69M573.48%1.25M2,572.20%7.88M70.14%12.11M1,222.50%8.58M782.58%3.5M-108.05%-264K
Investing cash flow
Cash flow from continuing investing activities 16,490.63%5.25M-104.20%-292K-46.38%-101K-14.29%-24K-1,025.00%-135K21.95%-32K0.00%-143K-228.57%-69K19.23%-21K-140.00%-12K
Net PPE purchase and sale -90.63%-61K-104.20%-292K-46.38%-101K-14.29%-24K-1,025.00%-135K21.95%-32K0.00%-143K-228.57%-69K19.23%-21K-140.00%-12K
Net business purchase and sale --5.8M------------------------------------
Net other investing changes ---494K------------------------------------
Cash from discontinued investing activities
Investing cash flow 16,490.63%5.25M-104.20%-292K-46.38%-101K-14.29%-24K-1,025.00%-135K21.95%-32K0.00%-143K-228.57%-69K19.23%-21K-140.00%-12K
Financing cash flow
Cash flow from continuing financing activities -173.75%-2.29M28.81%6.92M-102.13%-80K-85.76%148K528.02%3.74M22,278.57%3.11M6,065.56%5.37M5,031.58%3.75M34,733.33%1.04M6,060.00%596K
Net issuance payments of debt --0-9.09%-12K0.00%-2K0.00%-4K-50.00%-3K0.00%-3K26.67%-11K-100.00%-2K-33.33%-4K80.00%-2K
Net common stock issuance ---2.35M---251K--------------0--0------------
Proceeds from stock option exercised by employees -96.44%111K33.39%7.25M-93.99%228K-85.43%152K527.42%3.75M--3.11M--5.43M--3.79M--1.04M--598K
Net other financing activities -683.33%-47K-28.85%-67K-34.15%-55K--0---6K45.45%-6K30.67%-52K---41K--0--0
Cash from discontinued financing activities
Financing cash flow -173.75%-2.29M28.81%6.92M-102.13%-80K-85.76%148K528.02%3.74M22,278.57%3.11M6,065.56%5.37M5,031.58%3.75M34,733.33%1.04M6,060.00%596K
Net cash flow
Beginning cash position 45.07%64.79M63.44%44.66M98.44%64.29M116.87%60.47M101.76%55.62M63.44%44.66M33.68%27.33M21.01%32.4M5.60%27.89M19.12%27.57M
Current changes in cash -83.93%1.76M16.11%20.13M-95.94%498K-15.44%3.82M1,418.13%4.86M4,465.00%10.96M151.82%17.34M2,121.38%12.26M1,129.70%4.51M-90.20%320K
End cash Position 19.66%66.55M45.07%64.79M45.07%64.79M98.44%64.29M116.87%60.47M101.76%55.62M63.44%44.66M63.44%44.66M21.01%32.4M5.60%27.89M
Free cash flow -115.99%-1.26M10.60%13.21M-93.21%578K6.20%3.67M503.99%1.12M2,990.94%7.85M71.42%11.95M1,255.73%8.51M833.51%3.45M-108.44%-276K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran Show More